SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor drug development in depression? Does mismatch negativity have utility for NMDA receptor drug development in depression?
Por um escritor misterioso
Descrição
Rapid antidepressant effects associated with ketamine have shifted the landscape for the
Targeting NMDA receptors in neuropsychiatric disorders by drug
SciELO - Brasil - Estudos traducionais de neuropsiquiatria e
NMDA receptor trafficking in synaptic plasticity and
Frontiers Can N-Methyl-D-Aspartate Receptor Hypofunction in
Plants October-2 2022 - Browse Articles
SciELO - Brazil - Does mismatch negativity have utility for NMDA
NMDAR-dependent long-term depression is associated with increased
PDF) Cannabinoids and Vanilloids in Schizophrenia
Preso regulates NMDA receptor-mediated excitotoxicity via
Frontiers The NMDA receptor complex: a multifunctional machine
PDF) Changing prevalence and treatment of depression among older
